Global Animal Antimicrobials and Antibiotics Market 2015-2019
About Animal Antimicrobials and Antibiotics
Companion animals such as swine, cattle, horses, and fish are prone to various kinds of infections. Antimicrobials and antibiotics are used to treat these infections. Farm owners also use these drugs to accelerate the growth of animals, especially in the farms of North America and Europe. Similar to medicines used by humans, animal antimicrobials and antibiotics require authorization from the governments of the countries where it is being marketed. Lack of adherence to guidelines on antibiotic usage on farm animals can lead to over-use of antibiotics and result in drug-resistant strains of microorganisms. These can then be transferred to human beings through consumption of milk or meat.
Technavio's analysts forecast the global animal antimicrobials and antibiotics market to grow at a CAGR of 5.25% over the period 2014-2019.
Covered in this Report
This report covers the present scenario and the growth prospects of the global animal antimicrobials and antibiotics market for the period 2015-2019. To calculate the market size, the report considers revenue generated through sales of various antibiotics and antimicrobials intended for use in animals. Based on the chemical class of the drugs, the global animal antimicrobials and antibiotics market can be classified into the following:
Technavio Announces the Publication of its Research Report – Global Animal Antimicrobials and Antibiotics Market 2015-2019
Technavio recognizes the following companies as the key players in the global animal antimicrobials and antibiotics market: Bayer, Elanco, Merck Animal Health, Merial and Zoetis
Other Prominent Vendors in the market are: Animal Medics, Biogenesis Bago, Biovet, Boehringer Ingelheim, Ceva Holdings, Dechra Pharmaceuticals, ECO Animal Health, Huvepharma, Indian Immunologicals, Lillidale Animal Health, Mobedco (The Arab Pesticides & Veterinary Drugs), Neogen, Norbrook, Orion, Phibro Animal Health, Vétoquinol, Virbac and Vitafor
Commenting on the report, an analyst from Technavio’s team said: “The key players in the market are increasingly collaborating with academic institutions to develop innovative products for animal healthcare. For instance, in May 2013, Zoetis awarded $100,000 to Texas Tech University to provide resources for salmonella research. The Roslin Institute at the University of Edinburgh and Zoetis collaborated in July 2013 to jointly investigate the entry route, mechanism of persistence in cattle, and beef contamination by salmonella. The BBSRC funded this research. In 2013, Zoetis and the University of Minnesota collaborated to develop a diagnostic test for diseases caused by the porcine epidemic diarrhea virus. In February 2014, the Iowa State University and Zoetis signed a collaborative agreement to develop a vaccine for porcine epidemic diarrhea virus in the US. Such collaborations enable the amalgamation of research expertise of educational institutions with the marketing intelligence of pharma companies besides providing funds to conduct clinical trials.”
According to the report, the increasing population is resulting in a rise in the demand for food, including animal-based food. Limited farmlands, moreover, add to the pressure to serve the growing population. Further, increasing urbanization has created a shift in consumption patterns. Nutrient-dense foods such as meat are increasingly consumed when compared to the previous two decades. Rising income levels have also led to an increase in the purchasing of animal proteins, especially among the middle-income groups. Optimizing the yield of animal products such as milk and eggs, therefore, requires the raising of healthy, disease-free animals. This, in turn, has increased the focus of livestock rearers and the food industry on animal medicines to increase the efficiency of feed-to-meat/milk/egg conversion.
Further, the report states that stringent regulatory guidelines for obtaining market approvals of animal medicines are a major hindrance to market growth.
Bayer, Elanco, Merck Animal Health, Merial, Zoetis, Animal Medics, Biogenesis Bago, Biovet, Boehringer Ingelheim, Ceva Holdings, Dechra Pharmaceuticals, ECO Animal Health, Huvepharma, Indian Immunologicals, Lillidale Animal Health, Mobedco (The Arab Pesticides & Veterinary Drugs), Neogen, Norbrook, Orion, Phibro Animal Health, Vétoquinol, Virbac,Vitafor